Agenda
The Events
Over two days, these two co-located events will attract over 175 senior-level decision makers working in follow on biologics and cell culture in Asia, the US and Europe. This prestigious event provides a forum for practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 45 speakers will present a full conference programme covering the topics outlined below.
Biosimilars Asia Congress
Stream 1 – Biosimilars: Market Opportunities, Manufacture & Scale-Up
- Market opportunities & commercial challenges in US, Asia & emerging markets
- Regulatory challenges & developments
- Flexible & cost effective manufacture of high quality biosimilars
- Quality by design
- Pharmacovigilence
- Early stage selection considerations
- Single use systems and technology
- New production modes and platforms
Stream 2 – Developing Biosimilars: Opportunities & Challenges In Clinical Trials
- Complex proteins as biosimilars
- Clinical protocol & patient safety
- Increasing potency
- CMC considerations
- PK/PD testing
- Developing an efficient scale-up process
- Achieving quality by design
- Demonstrating biosimilarity & characterisation
Cell Culture Congress
Stream 1 – Cell Culture & Cell Line Development
- Advances in cell culture development
- Cell line contamination
- Cell line authentication
- Optimising cell line performance
- Cell culture growth mediums
- Cell culture in 3D
Stream 2 – Bioprocessing & Bioproduction
- Upstream processing
- Downstream processing
- Disposable & single use technology
- Scale down design
- Risk reduction strategies
- Optimal biotherapeutic production
- Analytical technologies
